本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

enVVeno Medical Corp.

4.18
-0.1400-3.24%
盘后4.520.3394+8.12%19:38 EDT
成交量:8.86万
成交额:37.67万
市值:7,330.05万
市盈率:-3.57
高:4.47
开:4.31
低:4.16
收:4.32
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/16

重要事件披露

Form 8-K - Current report
2023/11/02

SEC问询函

Form CORRESP - Correspondence
2023/10/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/12

重要事件披露

Form 8-K - Current report
2023/08/22

SEC问询函

Form CORRESP - Correspondence
2023/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/26

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/04/28

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/10/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/11

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/05/11

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2022/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans